Recent (July)  FDA drug approvals:  Previous Month

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone

Recent (July)  FDA drug approvals:

< Previous Month Next Month >


Drug Name

and
FDA Appl. #

Suppl. #

Active
Ingredients

Company

Approval
Type

Approval
Date
ORTHO EVRA
(NDA # 021180)

044 ETHINYL ESTRADIOL; NORELGESTROMIN JANSSEN PHARMS Labeling Revision 07/01/2013
TRACLEER
(NDA # 021290)

025 BOSENTAN ACTELION PHARMS LTD Labeling Revision 07/01/2013
RIZATRIPTAN BENZOATE
(ANDA # 078739)

000 RIZATRIPTAN BENZOATE SANDOZ Approval 07/01/2013
FINASTERIDE
(ANDA # 090060)

000 FINASTERIDE HETERO LABS LTD III Approval 07/01/2013
FINASTERIDE
(ANDA # 090508)

000 FINASTERIDE SUN PHARMA GLOBAL Approval 07/01/2013
RASAGILINE MESYLATE
(ANDA # 201823)

000 RASAGILINE MESYLATE WATSON LABS INC Approval 07/01/2013
RIZATRIPTAN BENZOATE
(ANDA # 201914)

000 RIZATRIPTAN BENZOATE GLENMARK GENERICS Approval 07/01/2013
ARIPIPRAZOLE
(ANDA # 202102)

000 ARIPIPRAZOLE ALEMBIC PHARMS LTD Tentative Approval 07/01/2013
RIZATRIPTAN BENZOATE
(ANDA # 202477)

000 RIZATRIPTAN BENZOATE APOTEX INC Approval 07/01/2013
GATIFLOXACIN
(ANDA # 202653)

000 GATIFLOXACIN LUPIN LTD Tentative Approval 07/01/2013
RILUZOLE
(ANDA # 203042)

000 RILUZOLE MYLAN PHARMS INC Approval 07/01/2013
RIZATRIPTAN BENZOATE
(ANDA # 203062)

000 RIZATRIPTAN BENZOATE AUROBINDO PHARMA LTD Approval 07/01/2013
RIZATRIPTAN BENZOATE
(ANDA # 203478)

000 RIZATRIPTAN BENZOATE NATCO PHARMA LTD Approval 07/01/2013
RIZATRIPTAN BENZOATE
(ANDA # 204339)

000 RIZATRIPTAN BENZOATE INVAGEN PHARMS Approval 07/01/2013
EFUDEX
(NDA # 016831)

056 FLUOROURACIL VALEANT PHARM INTL Manufacturing Change or Addition 07/02/2013
NASACORT AQ
(NDA # 020468)

033 TRIAMCINOLONE ACETONIDE SANOFI AVENTIS US Efficacy Supplement with Clinical Data to Support 07/02/2013
NASACORT AQ
(NDA # 020468)

034 TRIAMCINOLONE ACETONIDE SANOFI AVENTIS US Efficacy Supplement with Clinical Data to Support 07/02/2013
SPRIX
(NDA # 022382)

007 KETOROLAC TROMETHAMINE LUITPOLD Manufacturing Change or Addition 07/02/2013
ZIANA
(NDA # 050802)

014 CLINDAMYCIN PHOSPHATE; TRETINOIN MEDICIS Manufacturing Change or Addition 07/02/2013
ROSUVASTATIN CALCIUM
(ANDA # 079161)

000 ROSUVASTATIN CALCIUM MYLAN PHARMA Tentative Approval 07/02/2013
PEGASYS
(BLA # 103964)

5245 PEGINTERFERON ALFA-2A HOFFMAN-LA ROCHE Labeling Revision 07/02/2013
ACTEMRA
(BLA # 125276)

075 TOCILIZUMAB GENENTECH Labeling Revision 07/02/2013
SUBLIMAZE PRESERVATIVE FREE
(NDA # 016619)

034 FENTANYL CITRATE AKORN Labeling Revision 07/03/2013
TENEX
(NDA # 019032)

021 GUANFACINE HYDROCHLORIDE PROMIUS PHARMA Labeling Revision 07/03/2013
PERIOCHIP
(NDA # 020774)

013 CHLORHEXIDINE GLUCONATE DEXCEL PHARMA Manufacturing Change or Addition 07/03/2013
GEODON
(NDA # 020825)

041 ZIPRASIDONE HYDROCHLORIDE PFIZER Labeling Revision 07/03/2013
GEODON
(NDA # 020919)

027 ZIPRASIDONE MESYLATE PFIZER Labeling Revision 07/03/2013
BENICAR
(NDA # 021286)

027 OLMESARTAN MEDOXOMIL DAIICHI SANKYO Labeling Revision 07/03/2013
OXYTROL
(NDA # 021351)

007 OXYBUTYNIN WATSON LABS (UTAH) Manufacturing Change or Addition 07/03/2013
GEODON
(NDA # 021483)

007 ZIPRASIDONE HYDROCHLORIDE PFIZER INC Labeling Revision 07/03/2013
BENICAR HCT
(NDA # 021532)

022 HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL DAIICHI SANKYO Labeling Revision 07/03/2013
AZOR
(NDA # 022100)

022 AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL DAIICHI SANKYO Labeling Revision 07/03/2013
CAPRELSA
(NDA # 022405)

004 VANDETANIB IPR PHARMS INC Labeling Revision 07/03/2013
GABAPENTIN
(ANDA # 076672)

000 GABAPENTIN TARO Approval 07/03/2013
PROLIA
(BLA # 125320)

113 DENOSUMAB AMGEN Labeling Revision 07/03/2013
XGEVA
(BLA # 125320)

113 DENOSUMAB AMGEN Labeling Revision 07/03/2013
TRIBENZOR
(NDA # 200175)

014 AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL DAIICHI SANKYO Manufacturing Change or Addition 07/03/2013
TRIBENZOR
(NDA # 200175)

015 AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL DAIICHI SANKYO Labeling Revision 07/03/2013
ZELBORAF
(NDA # 202429)

002 VEMURAFENIB HOFFMANN LA ROCHE Labeling Revision 07/03/2013
ZELBORAF
(NDA # 202429)

003 VEMURAFENIB HOFFMANN LA ROCHE Labeling Revision 07/03/2013
ZOLEDRONIC ACID
(NDA # 204016)

000 ZOLEDRONIC ACID HOSPIRA INC Tentative Approval 07/03/2013
ZUBSOLV
(NDA # 204242)

000 BUPRENORPHINE; NALOXONE OREXO AB Approval                07/03/2013
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Couche-Tard's Q1 2027: Strong Growth Amid Challenges

Updated Category News Views 9

Decoding Alimentation Couche-Tard's Recent Gains When the talk in the finance circles centers around Alimentation Couche-Tard (TSX: ATD) these days, it's all about their jump into fiscal 2027. The giant convenience store operator dished out some promising numbers for their first quarter, rippling through Wall Street's coffee breaks. Net earnings for shareholders of $828.5...

Continue Reading
Penn State-Battalion Pact Advances Semiconductor and Alloy Tech

Updated Category News Views 16

Bridging Academia and Industry for Security Every so often, academia and industry find that sweet spot where their paths align. It's one of those days, it seems. Penn State University and Battalion Advanced Technology Ltd have cozied up for some big-ticket collaboration on materials research. They're not simply tossing money around—up to $6 million's earmarked for two...

Continue Reading
Check Point Shareholders Back 2026 AGM Proposals

Updated Category News Views 0

Shareholder Endorsement Solidifies Check Point's Strategy Today, Check Point Software Technologies had a bit of a celebratory mood. Their stakeholders, it seems, aren't just riding the wave; they're all in. You could almost hear the cheers from Redwood City when those shareholder voting results flashed across the board. Some 81.2 million shares—encompassing about 79.52%...

Continue Reading
Costa Rica's Summit Draws Global Investors, Buyers

Updated Category News Views 0

Costa Rica's Big Stage for Business and Opportunity You might look at Costa Rica and think of lush rainforests and coffee beans, but right now, it's a hub bustling with suits, spreadsheets, and strategic meetings. Over three days, the Costa Rica Trade & Investment Summit (CRTIS) gathered nearly half a thousand buyers and investors all under one roof in San José. Local...

Continue Reading
Manulife's $750M US Offering: Risky or Strategic?

Updated Category News Views 2

Manulife: Debuting $750M in Subordinated Notes When it comes to Manulife's latest move, it's all about the numbers. They've priced a U.S. public offering of a meaty $750 million in subordinated notes at an enticing 6.146% interest rate. That's no pocket change, folks, and it highlights a strategy or a gamble, depending on your view. But here's the kicker: these notes may...

Continue Reading
Replay Sports Cards Expands to Greenville With New Franchise

Updated Category News Views 0

An Old Hobby Gets New Life in Greenville Isn't it something when a hobby from your childhood eventually morphs into a business venture? That's exactly what's happening in Greenville, North Carolina, where Replay Sports Cards is laying down roots. Thanks to Jim and Jake Whitehurst's fresh franchise agreement, the card community along the eastern seaboard is about to have a...

Continue Reading
MD Integrations' Bold Cert Link: Telehealth's New Era

Updated Category News Views 1

MD Integrations Paves a New Path in Telehealth Well, folks, it seems someone’s finally listening. MD Integrations is taking a serious swing at solving one of telehealth's big hiccups – compliance delays. By roping in LegitScript directly, they’re all set to smooth the rocky road to launching virtual care brands. The Sticky Issue of Compliance Delays Anyone dabbling...

Continue Reading
York Urged to Retire Research Macaques After Probe

Updated Category News Views 0

Undercover Investigation Shakes Up York University If you thought the world of research was all about sterile labs and the pursuit of knowledge, think again. The Jane Goodall Institute (JGI), famed for championing animal welfare, has urged York University to let go of nine long-suffering rhesus macaques. Turns out, these macaques weren't exactly living their best lives....

Continue Reading
NEXA Unlimited: Disrupting Mortgage Broker Earnings

Updated Category News Views 7

What Exactly Is NEXA Unlimited? In a game-changer twist, NEXA Lending has launched something that could dramatically shuffle the current mortgage broker model deck. Dubbed NEXA Unlimited, this new model promises no less than 100% revenue access to its loan officers. We're talking zero fees—flat, funding, closing—none of ‘em. This isn't a small tweak or a cosmetic...

Continue Reading
Marco's Pizza Fuels Education with $1M Donation Boost

Updated Category News Views 1

It's not just about slinging pies for Marco's Pizza these days. They're marking a mighty milestone with a $1 million donation to Junior Achievement USA, a major player in prepping young folks to grapple with real-world financials and entrepreneurship. This hefty check not only pushes The Marco's Pizza Foundation's giving tally past the $1.5 million mark, but it also...

Continue Reading

Top 5 Most Recently Viewed Articles

Tempus AI: Important Legal Reminder for Investors

Updated Category News Views 112

Understanding Tempus AI's Legal Situation Tempus AI, Inc. has recently found itself at the center of a legal storm, and it's crucial for investors to be aware of the developments that could impact their interests. Bragar Eagel & Squire, P.C., a well-respected law firm, has been actively engaging with shareholders who have experienced losses. How Tempus AI Investors Can...

Continue Reading
Projected Growth of the Fatty Amines Market to $4.97 Billion

Updated Category News Views 214

Overview of the Fatty Amines Market The fatty amines market is poised for significant growth, with projections indicating an increase from USD 3.60 billion in 2025 to USD 4.97 billion by 2030. This growth, reflecting a compound annual growth rate (CAGR) of 6.7%, is attributed to heightened demand across various sectors. The Influence of Eco-friendly Practices As...

Continue Reading
NIP Group Finalizes Major Crypto Mining Assets Acquisition

Updated Category News Views 130

NIP Group Inc. Completes New Acquisition in Crypto Mining NIP Group Inc. (NASDAQ: NIPG), a trailblazer in the digital entertainment industry, has successfully finalized a significant acquisition of on-rack crypto mining machinery. This strategic move is designed to enhance their operational capacity, enabling them to accelerate growth in the crypto asset sector. Details...

Continue Reading
Understanding the Altimmune Class Action Lawsuit for Investors

Updated Category News Views 189

The Class Action Lawsuit Against Altimmune Investors affected by the recent events surrounding Altimmune (NASDAQ: ALT) have an opportunity to participate in an important class action lawsuit. The lawsuit was launched by Bragar Eagel & Squire, P.C., a renowned law firm specializing in stockholder rights. It pertains to all individuals who acquired securities of Altimmune...

Continue Reading
Koryx Copper's Promising Drill Insights Reveal Project Growth

Updated Category News Views 275

Exciting Drill Results from Koryx Copper's Haib Project Koryx Copper Inc. (TSX-V: KRY) has recently unveiled assay results that are making waves in the mining community. These results are derived from an active and promising drill program at the Haib Copper Project. This ongoing effort is part of Koryx’s strategy for exploration and project development. The current...

Continue Reading